Ka. Holmkvist et Rk. Roenigk, SQUAMOUS-CELL CARCINOMA OF THE LIP TREATED WITH MOHS MICROGRAPHIC SURGERY - OUTCOME AT 5 YEARS, Journal of the American Academy of Dermatology, 38(6), 1998, pp. 960-966
Background: Mohs micrographic surgery (MMS) is believed to be a highly
effective treatment of squamous cell carcinoma (SCC) of the lip. Obje
ctive: The goals of our study were to determine the long-term (5-year)
outcome of patients treated with MMS for SCC of the lip and to identi
fy factors associated with tumor recurrence. Methods: Clinical and his
topathologic data from 50 consecutive cases of SCC of the lip treated
with MMS were retrospectively reviewed. Results: There were no tumor-r
elated deaths or metastases. Forty-six patients (92%) remained free of
disease. Four patients (8%) were diagnosed with SCC at the surgical s
ite after MMS. Recurrent lesions tended to be superficial and occurred
in the setting of severe actinic cheilitis. The average time to diagn
osis after MMS was 2.5 years. All patients with recurrent disease were
treated with further MMS and had successful results. No recurrences w
ere seen among patients who received adjuvant treatment for actinic ch
eilitis with the carbon dioxide (CO2) laser, had clinical lesions 1 cm
or less in diameter, or had post-MMS defects 2 cm or less in diameter
. Conclusion: MMS is highly effective for treating both primary and re
current SCC of the lip. Treatment of coexisting actinic cheilitis may
lower the risk for local recurrence after MMS.